Decentralized Clinical Trials: The Future of Medical Product Development?∗
- PMID: 33997523
- PMCID: PMC8093545
- DOI: 10.1016/j.jacbts.2021.01.011
Decentralized Clinical Trials: The Future of Medical Product Development?∗
Keywords: COVID-19; blockchain; decentralized clinical trials; drug development; virtual clinical trials.
Conflict of interest statement
Dr. Van Norman has received funding from the American College of Cardiology for this publication.
Figures
References
-
- Khozin S., Coravox A. Decentralized trials in the age of real-world evidence and inclusivity in clinical investigations. Clin Pharmacol Ther. 2019;106:25–27. - PubMed
-
- Orri M., Lispet C.H., Jacobs B.P. Web-based trial to evaluate the efficacy and safety of tolterodine ER 4 mg in participants with overactive bladder: REMOTE trial. Contemp Clin Trials. 2014;38:190–197. - PubMed
-
- Clinical Trials Transformation Initiative CTTI recommendations: decentralized clinical trials. September 2018. https://www.ctti-clinicaltrials.org/sites/www.ctti-clinicaltrials.org/fi... Available at:
-
- U.S. Food and Drug Administration FDA guidance on conduct of clinical trials of medical products during COVID-19 public health emergency. https://www.fda.gov/regulatory-information/search-fda-guidance-documents... Available at:
LinkOut - more resources
Full Text Sources
